Literature DB >> 33584221

Muscle Synergies in Patients With Multiple Sclerosis Reveal Demand-Specific Alterations in the Modular Organization of Locomotion.

Lars Janshen1, Alessandro Santuz1,2, Adamantios Arampatzis1,2.   

Abstract

For patients with multiple sclerosis (MS), deficits in gait significantly reduce the quality of life. Using the concept of muscle synergies, this study investigated the modular organization of motor control during level and inclined walking in MS patients (MSP) compared with healthy participants (HP) to identify the potential demand-specific adjustments in motor control in MSP. We hypothesized a widening of the time-dependent activation patterns (motor primitives) in MSP to increase the overlap of temporally-adjacent muscle synergies, especially during inclined walking, as a strategy to increase the robustness of motor control, thus compensating pathology-related deficits. We analyzed temporal gait parameters and muscle synergies from myoelectric signals of 13 ipsilateral leg muscles using non-negative matrix factorization. Compared with HP, MSP demonstrated a widening in the time-dependent coefficients (motor primitives), as well as altered relative muscle contribution (motor modules), in certain synergies during level and inclined walking. Moreover, inclined walking revealed a demand-specific adjustment in the modular organization in MSP, resulting in an extra synergy compared with HP. This further increased the overlap of temporally-adjacent muscle synergies to provide sufficient robustness in motor control to accomplish the more demanding motor task while coping with pathology-related motor deficits during walking.
Copyright © 2021 Janshen, Santuz and Arampatzis.

Entities:  

Keywords:  demand-specific; inclined walking; locomotion; motor control; multiple sclerosis; muscle synergies

Year:  2021        PMID: 33584221      PMCID: PMC7873056          DOI: 10.3389/fnhum.2020.593365

Source DB:  PubMed          Journal:  Front Hum Neurosci        ISSN: 1662-5161            Impact factor:   3.169


  66 in total

Review 1.  Multiple sclerosis: current pathophysiological concepts.

Authors:  D M Wingerchuk; C F Lucchinetti; J H Noseworthy
Journal:  Lab Invest       Date:  2001-03       Impact factor: 5.662

2.  Three-dimensional modular control of human walking.

Authors:  Jessica L Allen; Richard R Neptune
Journal:  J Biomech       Date:  2012-06-21       Impact factor: 2.712

Review 3.  Combining modules for movement.

Authors:  E Bizzi; V C K Cheung; A d'Avella; P Saltiel; M Tresch
Journal:  Brain Res Rev       Date:  2007-09-05

4.  Subject-specific muscle synergies in human balance control are consistent across different biomechanical contexts.

Authors:  Gelsy Torres-Oviedo; Lena H Ting
Journal:  J Neurophysiol       Date:  2010-04-14       Impact factor: 2.714

5.  Muscle synergy patterns as physiological markers of motor cortical damage.

Authors:  Vincent C K Cheung; Andrea Turolla; Michela Agostini; Stefano Silvoni; Caoimhe Bennis; Patrick Kasi; Sabrina Paganoni; Paolo Bonato; Emilio Bizzi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

6.  Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction.

Authors:  Michelle H Cameron; Fay B Horak; Robert R Herndon; Dennis Bourdette
Journal:  Somatosens Mot Res       Date:  2008       Impact factor: 1.111

7.  Challenging human locomotion: stability and modular organisation in unsteady conditions.

Authors:  Alessandro Santuz; Antonis Ekizos; Nils Eckardt; Armin Kibele; Adamantios Arampatzis
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

8.  The Fuzziness of the Molecular World and Its Perspectives.

Authors:  Pier Luigi Gentili
Journal:  Molecules       Date:  2018-08-19       Impact factor: 4.411

9.  The Influence of Footwear on the Modular Organization of Running.

Authors:  Alessandro Santuz; Antonis Ekizos; Lars Janshen; Vasilios Baltzopoulos; Adamantios Arampatzis
Journal:  Front Physiol       Date:  2017-11-22       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.